Your browser doesn't support javascript.
loading
Efficacy and Safety of Vorapaxar by Intensity of Background Lipid-Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P-TIMI 50 Trial.
Gilchrist, Ian C; Morrow, David A; Creager, Mark A; Olin, Jeffrey W; Scirica, Benjamin M; Goodrich, Erica L; Bonaca, Marc P.
Afiliação
  • Gilchrist IC; Cardiovascular Division Department of Medicine Stony Brook University Medical Center Stony Brook NY.
  • Morrow DA; Cardiovascular Division Department of Medicine TIMI Study GroupBrigham and Women's Hospital and Harvard Medical School Boston MA.
  • Creager MA; Dartmouth-Hitchcock Medical CenterHeart and Vascular Center Lebanon NH.
  • Olin JW; Zena and Michael A. Wiener Cardiovascular InstituteIcahn School of Medicine at Mount Sinai New York NY.
  • Scirica BM; Cardiovascular Division Department of Medicine TIMI Study GroupBrigham and Women's Hospital and Harvard Medical School Boston MA.
  • Goodrich EL; Cardiovascular Division Department of Medicine TIMI Study GroupBrigham and Women's Hospital and Harvard Medical School Boston MA.
  • Bonaca MP; Division of Cardiology, and CPC Clinical Research Department of Medicine University of Colorado School of Medicine Aurora CO.
J Am Heart Assoc ; 10(20): e021412, 2021 10 19.
Article em En | MEDLINE | ID: mdl-34622665
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Acidente Vascular Cerebral / Doença Arterial Periférica Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Acidente Vascular Cerebral / Doença Arterial Periférica Idioma: En Ano de publicação: 2021 Tipo de documento: Article